Literature DB >> 1894434

Sucker-like structures in two strains of Acanthamoeba: scanning electron microscopy study.

J Diaz1, A Osuna, M J Rosales, J Cifuentes, C Mascaró.   

Abstract

Amebostomes are labile sucker-like structures repeatedly observed and described in Naegleria by different authors. Studying the phagocytic action of some Acanthamoeba species on Vero cells, the formation of similar structures to the Naegleria amebostomes was observed, apparently related to the phagocytic activity on cells.

Mesh：

Year:  1991        PMID： 1894434     DOI： 10.1016/0020-7519(91)90041-5

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN： 0020-7519            Impact factor:   3.981


  5 in total

1.  Role of the Nfa1 protein in pathogenic Naegleria fowleri cocultured with CHO target cells.

Authors:  Su-Yeon Kang; Kyoung-Ju Song; Seok-Ryoul Jeong; Jong-Hyun Kim; Sun Park; Kyongmin Kim; Myung-Hee Kwon; Ho-Joon Shin
Journal:  Clin Diagn Lab Immunol       Date:  2005-07

Review 2.  Acanthamoeba spp. as agents of disease in humans.

Authors:  Francine Marciano-Cabral; Guy Cabral
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

3.  Long-term survival of Naegleria polaris from Antarctica after 10 years of storage at 4 °C.

Authors:  Junji Matsuo; Shinji Nakamura; Torahiko Okubo; Manabu Fukui; Hiroyuki Yamaguchi
Journal:  Parasitol Res       Date:  2018-01-29       Impact factor: 2.289

4.  Induction of morphological and electrophysiological changes in hamster cornea after in vitro interaction with trophozoites of Acanthamoeba spp.

Authors:  Maritza Omaña-Molina; Fernando Navarro-García; Arturo González-Robles; José de Jesús Serrano-Luna; Rafael Campos-Rodríguez; Adolfo Martínez-Palomo; Víctor Tsutsumi; Mineko Shibayama
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

Review 5.  An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment.

Authors:  Jacob Lorenzo-Morales; Naveed A Khan; Julia Walochnik
Journal:  Parasite       Date:  2015-02-18       Impact factor: 3.000
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.